Sujal Shah

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 42% 8.2% 15.1%
Success rate 81% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sujal Shah's trades of Cymabay Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-12-11 2023-12-11
PrS Proposed sale
44,719
95.75
US$1,627,360 		44,719 95.75 US$1,627,360
2023-12-11 2023-12-11
PlS Planned sale
89,425 +43.7%
270.60
US$67,114 		89,425 +43.7% 270.60 US$67,114
2023-12-11 2023-12-11
PlS Planned sale
7,651 +15.6%
428.09
US$4,548,094 		7,651 +15.6% 428.09 US$4,548,094
2023-11-14 2023-11-13
PlS Planned sale
20,855 -10.9%
15.89
US$331,350 		20,855 -10.9% 15.89 US$331,350
2023-11-14 2023-11-13
PlS Planned sale
44,008 -20.4%
15.89
US$699,309 		44,008 -20.4% 15.89 US$699,309
2023-11-13 2023-11-13
PrS Proposed sale
64,863
15.89
US$1,030,655 		64,863 15.89 US$1,030,655
2023-10-10 2023-10-09
PrS Proposed sale
64,861
14.20
US$921,286 		64,861 14.20 US$921,286
2023-10-10 2023-10-09
PlS Planned sale
64,861 -27.5%
14.20
US$921,286 		64,861 -27.5% 14.20 US$921,286
2022-06-07 2022-06-06
B Purchase
51,301 +42.8%
1.95
US$100,037 		51,301 +42.8% 1.95 US$100,037
2019-10-15 2019-10-10
B Purchase
5,000 +4.3%
4.30
US$21,500 		5,000 +4.3% 4.30 US$21,500
2019-09-24 2019-09-23
B Purchase
3,100 +2.8%
5.55
US$17,205 		3,100 +2.8% 5.55 US$17,205
2019-09-24 2019-09-20
B Purchase
1,900 +1.7%
5.50
US$10,450 		1,900 +1.7% 5.50 US$10,450